HON
47
-12
PFE
30
-3
PPL
65
6
CF
57
-3
NEM
48
2
GOOGL
56
2
EXC
53
6
MSI
72
2
FMC
40
4
TROW
34
-5
BMY
56
3
HP
41
-4
PCAR
50
-3
HCP
64
-2
HOG
50
6
FOXA
48
7
T
56
2
ED
53
4
WFC
63
3
IBM
81
3
HON
47
-12
PFE
30
-3
PPL
65
6
CF
57
-3
NEM
48
2
GOOGL
56
2
EXC
53
6
MSI
72
2
FMC
40
4
TROW
34
-5
BMY
56
3
HP
41
-4
PCAR
50
-3
HCP
64
-2
HOG
50
6
FOXA
48
7
T
56
2
ED
53
4
WFC
63
3
IBM
81
3
Financhill
Back

ProPhase Labs Vs. OncoCyte Industry Stock Comparison

Sell
29

PRPH
ProPhase Labs

Last Price:
2.34
Seasonality Move:
20.16%
Sell
43

OCX
OncoCyte

Last Price:
3.28
Seasonality Move:
-0.82%
Sell
29
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $2.34. The Score for PRPH is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $3.28. The Score for OCX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $2.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight selling pressure.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $3.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OCX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 40.85 Sell
Chaikin Money Flow: -30930 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.77) Sell
Bollinger Bands (100): (2.65 - 4.77) Sell

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 57.87 Buy
Chaikin Money Flow: 41592 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.05 - 3.19) Buy
Bollinger Bands (100): (2.76 - 3.18) Buy

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.49 Sell
20-day SMA: 2.54 Sell
50-day SMA: 2.76 Sell
200-day SMA: 4.45 Sell
8-day EMA: 2.48 Sell
20-day EMA: 2.56 Sell
50-day EMA: 2.9 Sell
200-day EMA: 4.25 Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.09 Buy
20-day SMA: 3.11 Buy
50-day SMA: 3.13 Buy
200-day SMA: 2.98 Buy
8-day EMA: 3.11 Buy
20-day EMA: 3.11 Buy
50-day EMA: 3.08 Buy
200-day EMA: 3.34 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.38 per share, and an increase next year of $0.32 per share.

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):